The Impact of a Technology-enabled Decision Aid, for Patients With Hip and Knee Osteoarthritis on Decision Quality, Level of Shared Decision-making, Patient Satisfaction and Magnitude of Limitations

NCT ID: NCT03956004

Last Updated: 2020-08-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

145 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-03-28

Study Completion Date

2020-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates a technology-enabled decision aid that provides evidence-based education (i.e. on understanding the condition, treatment options and comparisons, patient values and question \& answer quiz) and personalized, quantifiable benefit-risk ratio alongside the level of potential benefit in relation to joint stiffness, joint pain and quality of life. The study will be performed in the setting of an integrated care system providing patient-centered care for hip and knee osteoarthritis over the full cycle of care. The impact of a technology-enabled decision aid incorporating predictive analytics with machine learning capabilities on decision quality, activation, experience \& limitations of patients in this setting is relatively unknown.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis, Knee

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental

Full decision aid, consisting of education on osteoarthritis and treatment options, preferences and values elicitation, and personalized risk/benefit estimates based on patient's response to patient-reported outcome measures.

Group Type EXPERIMENTAL

OM1 Dell Shared Decision Making Tool

Intervention Type OTHER

Decision aid meant to improve shared decision making among patients and providers.

Control

Education component of the decision aid only.

Group Type ACTIVE_COMPARATOR

Education material from OM1 Dell Shared Decision Making Tool

Intervention Type OTHER

Investigator-written educational material and quiz to test knowledge of osteoarthritis and treatment options.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

OM1 Dell Shared Decision Making Tool

Decision aid meant to improve shared decision making among patients and providers.

Intervention Type OTHER

Education material from OM1 Dell Shared Decision Making Tool

Investigator-written educational material and quiz to test knowledge of osteoarthritis and treatment options.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients with a presumptive diagnosis of knee OA aged between 45 and 89 (in-line with the decision aid algorithm)
* Radiographic evidence of moderate to severe osteoarthritis (Kellgren and Lawrence grade 3-4)
* KOOS Jr scores between 0-85 (in-line with the decision-aid algorithm)
* Participant able to give informed consent for participation in the study

Exclusion Criteria

* Kellgren and Lawrence scale for classification of osteoarthritis grade 0-2
* Patients with a prior experience of total joint replacement
* Patient with experience with the pilot form of the decision aid
* Patients undergoing consideration for revision joint replacement
* Patients seeking care for trauma condition or psoriatic/rheumatoid arthritis
* Non-English or Non-Spanish speakers
* Patients with BMI below 20 or above 46 (in-line with the decision-aid algorithm)
Minimum Eligible Age

45 Years

Maximum Eligible Age

89 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Texas at Austin

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kevin Bozic

Professor of Surgery

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kevin Bozic

Role: PRINCIPAL_INVESTIGATOR

Dell Medical School at The University of Texas at Austin

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UT Health Austin

Austin, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Jayakumar P, Moore MG, Furlough KA, Uhler LM, Andrawis JP, Koenig KM, Aksan N, Rathouz PJ, Bozic KJ. Comparison of an Artificial Intelligence-Enabled Patient Decision Aid vs Educational Material on Decision Quality, Shared Decision-Making, Patient Experience, and Functional Outcomes in Adults With Knee Osteoarthritis: A Randomized Clinical Trial. JAMA Netw Open. 2021 Feb 1;4(2):e2037107. doi: 10.1001/jamanetworkopen.2020.37107.

Reference Type DERIVED
PMID: 33599773 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2018-11-0042

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.